Functional Independence, Hemiparesis, Movement Disorder, Stroke
Conditions
Brief summary
The purpose of this study is to determine whether domiciliary VR-based telerehabilitation is superior than domiciliary occupational therapy for inducing functional gains, enhancing corticospinal excitability, and cortical reorganization.
Interventions
BEHAVIORALDomiciliary VR-based motor rehabilitation
3 weeks, 1 to 3 sessions a day, 20min per sessions, of physical therapy using a VR gaming system.
BEHAVIORALDomiciliary occupational therapy for motor rehabilitation
3 weeks, 1 to 3 sessions a day, 20min per sessions, of physical therapy using a VR gaming system.
Sponsors
Hospital del Mar
Hospital Vall d'Hebron
Universitat Pompeu Fabra
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
45 Years to 85 Years
Healthy volunteers
No
Inclusion criteria
* Clinical diagnosis of Hemorrhagic or ischemic stroke * Subject had the stroke more than 12 months ago. * Subject presents mild-to-moderate upper-limbs hemiparesis (Proximal Medial Research Council Scale\>2) secondary to a first-ever stroke. * Age between 45 and 85 years old. * Subject has previous experience using the RGS system in the clinic.
Exclusion criteria
* Subject presents a major cognitive impairment (Mini-Mental State Evaluation\> 22).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in motor function for activities of daily living as measured by Chedoke Arm Hand Inventory clinical | At baseline, at 3-weeks (after intervention), and at 12-weeks follow-up. |
Secondary
| Measure | Time frame |
|---|---|
| Change in motor function as measured by the Medical Research Council scale | At baseline, at 3-weeks (after intervention), and at 12-weeks follow-up. |
| Change in spasticity for the upper arms as measured by the Ashworth scale | At baseline, at 3-weeks (after intervention), and at 12-weeks follow-up. |
| Change in cognitive function as measured by the Mini-mental State Evaluation test | At baseline, at 3-weeks (after intervention), and at 12-weeks follow-up. |
| Change in depression as measured by the Hamilton scale | At baseline, at 3-weeks (after intervention), and at 12-weeks follow-up. |
| Change in shoulder pain as measured by the Visual Analog Assessment scale | At baseline, at 3-weeks (after intervention), and at 12-weeks follow-up. |
| Change in motor function as measured by the upper extremity Fugl-Meyer Assessment | At baseline, at 3-weeks (after intervention), and at 12-weeks follow-up. |
| Change in Grip Force as measured by a grip dynamometer | At baseline, at 3-weeks (after intervention), and at 12-weeks follow-up. |
Outcome results
None listed